![](https://www.genosciencepharma.com/wp-content/uploads/2019/07/Mr-Halfon.jpg)
Successful Entrepreneurship
President and Co-founder of Alphabio
Head of Internal Medicine, European Hospital in Marseille
Associate Professor, Medical College Paris
Expert in Oncogenetic
International expertise in hepatic diseases
Over 250 publications
H Index > 65
President and Co-founder of Alphabio
Head of Internal Medicine, European Hospital in Marseille
Associate Professor, Medical College Paris
Expert in Oncogenetic
International expertise in hepatic diseases
Over 250 publications
H Index > 65
![](https://www.genosciencepharma.com/wp-content/uploads/2021/02/AGNES-MENUT.jpg)
Pharmacist & Business management
13 years in Business Development and project management in R&D Oncology at Sanofi and Immuno-Oncology at MI-mABs
Oncology lead discovery up to submission phase (Anti-vascular drug in Sarcoma Phase 2, oncology vaccine in Renal Phase 3, Anti-angiogenic, kinase inhibitor… at early stages)
13 years in Business Development and project management in R&D Oncology at Sanofi and Immuno-Oncology at MI-mABs
Oncology lead discovery up to submission phase (Anti-vascular drug in Sarcoma Phase 2, oncology vaccine in Renal Phase 3, Anti-angiogenic, kinase inhibitor… at early stages)
![](https://www.genosciencepharma.com/wp-content/uploads/2018/10/Eric-Raymond-1-concentrate.png)
Renown Key Opinion Leader in Oncology
Lead the Oncology Department of the Hospital St Joseph, Paris
Participation in high number of Sponsored Clinical Trial in Oncology, phase 2 controlled, phase 3 trials up to registration process
Advisory Board Member for Pfizer, Novertis, Bayer, Merck-Serono, Ipsen, Sanofi, MSD, GSK
Over 175 publications
H Index > 65
Lead the Oncology Department of the Hospital St Joseph, Paris
Participation in high number of Sponsored Clinical Trial in Oncology, phase 2 controlled, phase 3 trials up to registration process
Advisory Board Member for Pfizer, Novertis, Bayer, Merck-Serono, Ipsen, Sanofi, MSD, GSK
Over 175 publications
H Index > 65